Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new apoptotic pathway for the complement factor B-derived fragment Bb.

M Uwai1, Y Terui, Y Mishima

  • 1Department of Hematology, Jichi Medical School, Kawachi, Tochigi, Japan.

Journal of Cellular Physiology
|October 12, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Induced Pluripotent Stem Cell-Derived Hematopoietic Embryoid Bodies Improve Mouse Status in Septic Peritonitis.

Bulletin of experimental biology and medicine·2019
Same author

Induced Pluripotent Stem Cell-Derived Hematopoietic Embryoid Bodies Secrete Sphingosine-1-Phosphate and Revert Endothelial Injury.

Bulletin of experimental biology and medicine·2018
Same author

High pretreatment level of soluble interleukin-2 receptor is a robust prognostic factor in patients with follicular lymphoma treated with R-CHOP-like therapy.

Blood cancer journal·2017
Same author

Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma.

Blood cancer journal·2017
Same author

Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma.

Blood cancer journal·2017
Same author

Establishment of optimized ELISA system specific for HLA-G in body fluids.

HLA·2016

A complement factor B fragment, Bb, induces apoptosis in leukemia cells. This discovery reveals a novel suicide mechanism in myeloid cells, crucial for cancer research.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • Apoptosis plays a key role in the immune system's tumor destruction.
  • Complement factor B is known to induce apoptosis in leukemia cell lines.

Purpose of the Study:

  • To identify and characterize the apoptosis-inducing factor from HL-60 myeloid leukemia cells.
  • To elucidate the mechanism of factor B-induced apoptosis in leukemic cells.

Main Methods:

  • Purification and sequencing of the apoptosis-inducing factor.
  • Use of monoclonal antibodies to inhibit apoptotic activity.
  • Investigation of TNF/TNFR and FasL/Fas pathways.
  • Identification of CD11c (iC3bR) as a binding partner for fragment Bb.

Related Experiment Videos

Main Results:

  • The apoptosis-inducing factor was identified as human complement factor B-derived fragment Bb.
  • Monoclonal antibodies against Bb, but not Ba, inhibited Bb-induced apoptosis.
  • Apoptotic activity was enhanced under conditions favoring Bb formation.
  • Factor B-induced apoptosis was independent of TNF/TNFR and FasL/Fas interactions.
  • CD11c (iC3bR) was identified as the primary binding subunit for Bb in the apoptosis pathway.

Conclusions:

  • Fragment Bb possesses a previously unrecognized function in inducing apoptosis in leukemic cells.
  • This apoptosis is mediated through a myeloid cell-specific suicide mechanism during differentiation.
  • The findings provide new insights into targeted cancer therapies for leukemia.